| Screening older cancer patients: first evaluation of the G-8 geriatric screening tool CA Bellera, M Rainfray, S Mathoulin-Pélissier, C Mertens, F Delva, ... Annals of Oncology 23 (8), 2166-2172, 2012 | 960 | 2012 |
| Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study P Soubeyran, C Bellera, J Goyard, D Heitz, H Curé, H Rousselot, ... PloS one 9 (12), e115060, 2014 | 542 | 2014 |
| Predictors of early death risk in older patients treated with first-line chemotherapy for cancer P Soubeyran, M Fonck, C Blanc-Bisson, JF Blanc, J Ceccaldi, C Mertens, ... Journal of Clinical Oncology 30 (15), 1829-1834, 2012 | 487 | 2012 |
| Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer CA Bellera, G MacGrogan, M Debled, CT De Lara, V Brouste, ... BMC medical research methodology 10, 1-12, 2010 | 414 | 2010 |
| Functional decline in older patients with cancer receiving first-line chemotherapy S Hoppe, M Rainfray, M Fonck, L Hoppenreys, JF Blanc, J Ceccaldi, ... Journal of Clinical Oncology 31 (31), 3877-3882, 2013 | 247 | 2013 |
| Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression L Vanhersecke, M Brunet, JP Guégan, C Rey, A Bougouin, S Cousin, ... Nature cancer 2 (8), 794-802, 2021 | 238 | 2021 |
| Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial A Italiano, O Mir, S Mathoulin-Pelissier, N Penel, S Piperno-Neumann, ... The lancet oncology 21 (3), 446-455, 2020 | 237 | 2020 |
| Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in … S Gourgou-Bourgade, D Cameron, P Poortmans, B Asselain, D Azria, ... Annals of Oncology 26 (5), 873-879, 2015 | 219 | 2015 |
| Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. P Soubeyran, C Bellera, J Goyard, D Heitz, H Cure, H Rousselot, ... Journal of Clinical Oncology 29 (15_suppl), 9001-9001, 2011 | 185 | 2011 |
| Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study M Savina, A Le Cesne, JY Blay, I Ray-Coquard, O Mir, M Toulmonde, ... BMC medicine 15, 1-11, 2017 | 182 | 2017 |
| A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer IC van Walree, E Scheepers, L van Huis-Tanja, MH Emmelot-Vonk, ... Journal of geriatric oncology 10 (6), 847-858, 2019 | 152 | 2019 |
| Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label … M Toulmonde, M Pulido, I Ray-Coquard, T André, N Isambert, ... The Lancet Oncology 20 (9), 1263-1272, 2019 | 145 | 2019 |
| Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort A Italiano, A Bessede, M Pulido, E Bompas, S Piperno-Neumann, ... Nature medicine 28 (6), 1199-1206, 2022 | 120 | 2022 |
| Validation of a screening test for elderly patients in oncology P Soubeyran, CA Bellera, F Gregoire, J Blanc, J Ceccaldi, C Blanc-Bisson, ... Journal of Clinical Oncology 26 (15_suppl), 20568-20568, 2008 | 103 | 2008 |
| Regorafenib-avelumab combination in patients with microsatellite stable colorectal cancer (REGOMUNE): a single-arm, open-label, phase II trial S Cousin, C Cantarel, JP Guegan, C Gomez-Roca, JP Metges, A Adenis, ... Clinical Cancer Research 27 (8), 2139-2147, 2021 | 101 | 2021 |
| Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative RS Puijk, M Ahmed, A Adam, Y Arai, R Arellano, T de Baère, R Bale, ... Radiology 301 (3), 533-540, 2021 | 89 | 2021 |
| GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute single-arm phase II collaborative study A Italiano, A Le Cesne, C Bellera, S Piperno-Neumann, F Duffaud, ... Annals of oncology 24 (11), 2922-2926, 2013 | 88 | 2013 |
| Normal Approximations to the Distributions of the Wilcoxon Statistics: Accurate to What N? Graphical Insights CA Bellera, M Julien, JA Hanley Journal of Statistics Education 18 (2), 2010 | 88 | 2010 |
| Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft‐tissue sarcoma patients in the competing risks setting A Italiano, A Le Cesne, J Mendiboure, JY Blay, S Piperno‐Neumann, ... Cancer 120 (21), 3361-3369, 2014 | 87 | 2014 |
| One-year mortality in older patients with cancer: development and external validation of an MNA-based prognostic score I Bourdel-Marchasson, A Diallo, C Bellera, C Blanc-Bisson, J Durrieu, ... PloS one 11 (2), e0148523, 2016 | 84 | 2016 |
